A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids

PHASE3CompletedINTERVENTIONAL

Enrollment

239

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

February 28, 2005

Study Completion Date

February 28, 2005

Conditions

Fibroid UterusLeiomyomaMenorrhagiaMetrorrhagiaUterine Fibroids

Interventions

DRUG

Asoprisnil

Asoprisnil 10 mg Tablet, oral Daily for 6 months

DRUG

Asoprisnil

Asoprisnil 25mg Tablet, oral Daily for 6 months

DRUG

Placebo

Placebo Tablet, oral Daily for 6 months